File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0306-3623(91)90062-B
- Scopus: eid_2-s2.0-0025726680
- PMID: 1936893
- WOS: WOS:A1991FT38300005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Calcium antagonists inhibit contractions to norepinephrine in the rat aorta, in the absence, but not in the presence of the endothelium
Title | Calcium antagonists inhibit contractions to norepinephrine in the rat aorta, in the absence, but not in the presence of the endothelium |
---|---|
Authors | |
Issue Date | 1991 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/vph |
Citation | General Pharmacology, 1991, v. 22 n. 4, p. 595-602 How to Cite? |
Abstract | To compare the effect of diltiazem and verapamil on the responsiveness of vascular smooth muscle to norepinephrine in the presence and absence of the endothelium, rings of rat aorta were studied in organ chambers. The removal of the endothelium decreased the ED50 to norepinephrine and augmented the maximal response to the catecholamine. The contraction to norepinephrine consisted of a rapid initial (phasic) and a (tonic) part. The tonic part was reduced in the presence of the endothelium. Diltiazem shifted the concentration-response curve to norepinephrine to the right only in rings without endothelium and reduced the difference in maximal response between rings with and without endothelium. Verapamil abolished the difference in sensitivity (ED50) between rings with and without endothelium. Oxyhemoglobin prevented the inhibitory effect of the endothelium on the response to norepinephrine, and unmasked a shift of the ED50 to the catecholamine to the right by diltiazem in rings with endothelium. These experiments suggest that spontaneously released endothelium-derived relaxing factor(s) is a functional antagonist of norepinephrine-induced contractions, presumably by reducing the stimulated influx of extracellular Ca2+. |
Persistent Identifier | http://hdl.handle.net/10722/171000 |
ISSN | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | AuchSchwelk, W | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:11:46Z | - |
dc.date.available | 2012-10-30T06:11:46Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | General Pharmacology, 1991, v. 22 n. 4, p. 595-602 | en_US |
dc.identifier.issn | 0306-3623 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171000 | - |
dc.description.abstract | To compare the effect of diltiazem and verapamil on the responsiveness of vascular smooth muscle to norepinephrine in the presence and absence of the endothelium, rings of rat aorta were studied in organ chambers. The removal of the endothelium decreased the ED50 to norepinephrine and augmented the maximal response to the catecholamine. The contraction to norepinephrine consisted of a rapid initial (phasic) and a (tonic) part. The tonic part was reduced in the presence of the endothelium. Diltiazem shifted the concentration-response curve to norepinephrine to the right only in rings without endothelium and reduced the difference in maximal response between rings with and without endothelium. Verapamil abolished the difference in sensitivity (ED50) between rings with and without endothelium. Oxyhemoglobin prevented the inhibitory effect of the endothelium on the response to norepinephrine, and unmasked a shift of the ED50 to the catecholamine to the right by diltiazem in rings with endothelium. These experiments suggest that spontaneously released endothelium-derived relaxing factor(s) is a functional antagonist of norepinephrine-induced contractions, presumably by reducing the stimulated influx of extracellular Ca2+. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/vph | en_US |
dc.relation.ispartof | General Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Aorta, Thoracic - Drug Effects - Physiology | en_US |
dc.subject.mesh | Calcium - Antagonists & Inhibitors | en_US |
dc.subject.mesh | Diltiazem - Pharmacology | en_US |
dc.subject.mesh | Endothelium, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Nitroprusside - Pharmacology | en_US |
dc.subject.mesh | Norepinephrine - Pharmacology | en_US |
dc.subject.mesh | Oxyhemoglobins - Pharmacology | en_US |
dc.subject.mesh | Rats | en_US |
dc.subject.mesh | Rats, Inbred Wky | en_US |
dc.subject.mesh | Vasoconstriction - Drug Effects - Physiology | en_US |
dc.subject.mesh | Verapamil - Pharmacology | en_US |
dc.title | Calcium antagonists inhibit contractions to norepinephrine in the rat aorta, in the absence, but not in the presence of the endothelium | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0306-3623(91)90062-B | - |
dc.identifier.pmid | 1936893 | - |
dc.identifier.scopus | eid_2-s2.0-0025726680 | en_US |
dc.identifier.volume | 22 | en_US |
dc.identifier.issue | 4 | en_US |
dc.identifier.spage | 595 | en_US |
dc.identifier.epage | 602 | en_US |
dc.identifier.isi | WOS:A1991FT38300005 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | AuchSchwelk, W=7003395589 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0306-3623 | - |